The mechanism of action of Botrychium (Thunb.) Sw. for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics.

Yutao LouXiaozhou ZouZongfu PanZhongjie HuangShuilian ZhengXiaowei ZhengXiuli YangMeihua BaoYuan ZhangJinping GuYiwen Zhang

Published in: The Journal of pharmacy and pharmacology (2024)

Our study not only clarifies the potential anti-fibrotic mechanism of BT against IPF at the metabolic level but also provides a theoretical basis for developing BT as an effective anti-fibrotic agent.

Keyphrases

idiopathic pulmonary fibrosis
interstitial lung disease
magnetic resonance
mass spectrometry
systemic sclerosis
solid state